Clinical Trials in North Carolina

Showing 2281-2300 of 20,428 trials

PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy

NCT07271758

This pilot study will explore feasibility of routine implementation of the recommended blood-based screening of DHA status in early pregnancy in routine clinical care.

Nutrient Deficiency

Wake Forest University Health Sciences650 participantsStarted May 2026

Winston-Salem, North Carolina, United States

RECRUITINGPhase 341 miles

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

NCT06513962

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with an alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. If the ovaries are not working well or completely shut down, then it will be difficult or impossible to get pregnant in the future. Triptorelin works by blocking certain hormones and causing the ovaries to slow down or pause normal activity. The triptorelin used in this study stays active in the body for 24 weeks or about 6 months after a dose is given. After triptorelin is cleared from the body, the ovaries resume normal activities. Adding triptorelin before the start of chemotherapy treatment may reduce the chances of damage to the ovaries.

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Children's Oncology Group60 participantsStarted Feb 2025

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +184 more locations

PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Find Trials by Condition in North Carolina

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder

Clinical Validation of the RENISCHEM L-FABP POC Assay

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Incomplete Cervical SCI Without Instability

Myositis Interstitial Lung Disease Nintedanib Trial

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

Prospective Study to Determine the Factors Influencing Infant Colic